Digital Karyotyping Identifies Genes Linked to Liver Cancer
Author Information
Author(s): Dong Hui, Zhang Hongyi, Liang Jianping, Yan Huadong, Chen Yangyi, Shen Yan, Kong Yalin, Wang Shengyue, Zhao Guoping, Jin Weirong
Primary Institution: Chinese National Human Genome Center at Shanghai
Hypothesis
The amplification at the 7q21.3 locus may contribute to the development or progression of hepatocellular carcinoma (HCC).
Conclusion
The study found that the 7q21.3 region is amplified in HCC, with SGCE, PEG10, and DYNC1I1 identified as probable oncogenes.
Supporting Evidence
- 821,252 genomic tags were obtained from the digital karyotyping library of HCC.
- 64% of the tags were mapped to unique loci of the human genome.
- Genomic amplification of SGCE, PEG10, DYNC1I1, and SLC25A13 was observed in 11 (21%) and 23 (44%) of the 52 HCC samples respectively.
- SGCE, PEG10, and DYNC1I1 were significantly up-regulated in tumorous liver tissues compared to nontumorous counterparts.
Takeaway
Researchers looked at liver cancer samples and found that certain genes were more active in cancerous tissues, which might help us understand how the cancer grows.
Methodology
Digital karyotyping was used to analyze genomic amplifications and deletions, followed by real-time quantitative PCR to validate findings.
Limitations
The study focused on a limited number of genes and samples, which may not represent all cases of HCC.
Participant Demographics
Patients were HBV-positive primary HCC patients who underwent curative surgery.
Statistical Information
P-Value
p<0.05 for SGCE, PEG10, and DYNC1I1; p=0.07 for DYNC1I1 after Bonferroni correction.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website